Sini Li

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Treatment-Related Adverse Events of Antibody-Drug Conjugate Monotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Treatment-Related Adverse Events of Antibody-Drug Conjugate Monotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: Thoracic cancer
Published: July 06, 2025

Lipocalin-2 drives brain metastatic progression through reciprocal tumor-microenvironment interactions in lung cancer.

Lipocalin-2 drives brain metastatic progression through reciprocal tumor-microenvironment interactions in lung cancer.

Journal: Signal transduction and targeted therapy
Published: April 16, 2025

Comparative investigation of neoadjuvant chemoimmunotherapy versus perioperative (chemo)immunotherapy in resectable non-small cell lung cancer: a real-world retrospective cohort study.

Comparative investigation of neoadjuvant chemoimmunotherapy versus perioperative (chemo)immunotherapy in resectable non-small cell lung cancer: a real-world retrospective cohort study.

Journal: Translational lung cancer research
Published: March 15, 2025

ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201.

ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201.

Journal: EBioMedicine
Published: August 06, 2024

Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.

Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity.

Journal: Cell reports. Medicine
Published: March 21, 2023

Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.

Abnormal activation of NF-κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid-derived suppressor cells to shape the immunosuppressive tumor immune microenvironment.

Journal: Thoracic cancer
Published: March 13, 2023

Comprehensive Analyses and Immunophenotyping of LIM Domain Family Genes in Patients with Non-Small-Cell Lung Cancer.

Comprehensive Analyses and Immunophenotyping of LIM Domain Family Genes in Patients with Non-Small-Cell Lung Cancer.

Journal: International journal of molecular sciences
Published: January 12, 2023

Tumour-derived exosomes in liver metastasis: A Pandora's box.

Tumour-derived exosomes in liver metastasis: A Pandora's box.

Journal: Cell proliferation
Published: January 05, 2023

Dynamic toxicity landscape of immunotherapy for solid tumors across treatment lines.

Dynamic toxicity landscape of immunotherapy for solid tumors across treatment lines.

Journal: Journal of the National Cancer Center
Published: December 23, 2022

Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis.

Comparative proteomic profiling of plasma exosomes in lung cancer cases of liver and brain metastasis.

Journal: Cell & bioscience
Published: October 17, 2022

WITHDRAWN: Proteomic analysis of plasma-derived exosomes identifies biomarkers that distinguish brain and liver metastasis in lung cancer patients.

WITHDRAWN: Proteomic analysis of plasma-derived exosomes identifies biomarkers that distinguish brain and liver metastasis in lung cancer patients.

Journal: Cancer letters
Published: May 19, 2022

Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review.

Tumor immune microenvironment in epidermal growth factor receptor-mutated non-small cell lung cancer before and after epidermal growth factor receptor tyrosine kinase inhibitor treatment: a narrative review.

Journal: Translational lung cancer research
Published: July 16, 2021
Showing 1-12 of 19

Last Updated: 09/26/2026